IT Support Services

Cell Panel Screening Service

The Cell Panel Screening technique is employed to assess the therapeutic impacts of test compounds on a variety of human cancer cell lines. LeadQuest Biotech’s Cell Bank houses an extensive collection of over 800 cell strains, including a comprehensive array of more than 500 human tumor cell lines specifically for Cell Panel screening. This approach spans more than 30 cancer types, encompassing a wide range of prevalent malignancies such as lung, lymphoma, gastric, breast, prostate, and colorectal cancers.



  • Identification of responsive tumor cell lines.
  • Ascertainment of suitable indications.
  • Selection of the most responsive tumor cell lines for cell modeling or patient-derived xenografts (PDX).
  • Assessment of genomic profiles to predict responses to anti-cancer therapies (optional).
  • Drug Efficacy Evaluation of test compounds on different human cancer cell lines.


List of Service

1.Customizable Cell Panels


1)LeadQuest Biotech Cell Bank maintains a vast repository of over 500 human tumor cell lines, with an addition of 50 cell lines monthly.

2)Collaborators may select any human tumor cell lines from our bank to assemble a customized Cell Panel for their specific compound screening.


2.Standard Cell Panels

A selection of 170 human tumor cell lines representing 21 tumor types.


Study Design



1)High control: solvent.

2)Low control: culture medium.

3)Positive control agent: staurosporine.


2.Sample Requirements

Generally, a 100 µL stock solution at 1000× the maximum test concentration (solid compounds should be prepared accordingly).


3.Biomarker and Proteolysis Analysis (optional)



  • Inoculation of cells in 384-well plates.
  • Overnight incubation, followed by automated addition of test compounds via ECHO.
  • Maintenance of cells under COA-specified conditions.
  • Utilization of the CellTiter-Glo assay.




  • Immediate initiation of testing upon receipt.
  • Cost-effective budgeting.
  • Expedited experimental timeline.
  • Consistent, reproducible data.
  • Compatibility with both single and combination drug assessments.
  • Comprehensive bioinformatics analysis (optional).


Other Testing Methods